Sara Martín‐Parra

Sara Martín‐Parra

Auto-generated profile, based on publicly available information

Sara Martín‐Parra

ICOnnecta't Digital Health Program Catalan Institute of Oncology Hospitalet del Llobregat Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2024 in European Neuropsychopharmacology
Verified
Journal Article
Open access
LMLaura Montejo
Laura Montejo
BSBrisa Sole
Brisa Sole
GFGiovanna Fico
Giovanna Fico
JKJanos L. Kalman
Janos L. Kalman
MBMonika Budde
Monika Budde
CTCarla Torrent
Carla Torrent
Older Adults with Bipolar Disorder (OABD) represent a heterogeneous group, including those with early and late onset of the disorder. Recent evidence shows both groups have distinct clinical, cognitive, and medical features, tied to different neurobiological profiles. This study explored the link between polygenic risk scores (PRS) for bipolar disorder (PRS-BD), schizophrenia (PRS-SCZ), and major depressive disorder (PRS-MDD) with age of onset in OABD. PRS-SCZ, PRS-BD, and PRS-MDD among early vs late onset were calculated. PRS was used to infer posterior SNP effect sizes using a fully Bayesian approach. Demographic, clinical, and cognitive variables were also analyzed. Logistic regression analysis was used to estimate the amount of variation of each group explained by standardized PRS-SCZ, PRS-MDD, and PRS-BD. A total of 207 OABD subjects were included (144 EOBD; 63 LOBD). EOBD showed higher PRS-BD compared to LOBD (p = 0.005), while no association was found between age of onset and PRS-SCZ or PRS-MDD. Compared to LOBD, EOBD individuals also showed a higher likelihood for suicide attempts (p = 0.01), higher presence of psychotic symptoms (p = 0.003), higher prevalence of BD-I (p = 0.002), higher rates of familiarity for any psychiatric disorder (p = 0.004), and lower processing speed measured with Trail-Making Test part A (p = 0.03). OABD subjects with an early onset showed a greater genetic burden for BD compared to subjects with a late onset. These findings contribute to the notion that EOBD and LOBD may represent different forms of OABD, particularly regarding the genetic predisposition to BD.

21 April 2026 in Psycho-Oncology
Verified
Journal Article
Open access
LCLaura Ciria-Suarez
Laura Ciria-Suarez
MHMelissa Heifez
Melissa Heifez
SMSara Martín‐Parra
Sara Martín‐Parra
IDIlaria Durosini
Ilaria Durosini
DMDario Monzani
Dario Monzani
COCristian Ochoa-Arnedo
Cristian Ochoa-Arnedo
Background: Cancer negatively affects patients' physical status as well as their mental health, increasing the burden of family members and caregivers as well. Thus, the screening of psychological and cognitive functioning is key for the referral to mental health specialists. Aim: Identify available and validated screening tools to assess psychological, psychosocial and cognitive impairment in cancer patients (adults and children), caregivers and family members. Methods: An umbrella review was conducted according to PRISMA guidelines. The search strategy was applied to five databases. Reviewers screened titles/abstracts, and the articles included in this initial phase were retrieved for full‐text assessment. All conflicts during the screening phase were discussed, and a third reviewer was consulted if discrepancies were not solved. A narrative synthesis and tabulated summaries of results were conducted. Results: A total of 2304 records were initially identified through systematic searches. Following screening and eligibility assessment, 67 systematic reviews were included. Across the included reviews, 586 different tools were identified and classified into nine thematic domains: (1) Anxiety and Depression, (2) General Mental Disorders, (3) Distress and Fear of Cancer Recurrence, (4) Body Image, Sexuality, and Self‐Perception, (5) Caregiving and Social Impact, (6) Cognitive Functioning, (7) Coping Assessment, (8) Unmet Needs, and (9) Other miscellaneous constructs. Conclusions: A wide variety of mental health screening tools are available, covering key psychosocial and cognitive aspects relevant to cancer care. Although most instruments were not specifically developed for oncological populations, many have been validated in this context and appear to perform adequately.

7 October 2026 in Applied Psychology: Health and Well-Being
Verified
Journal Article
Open access
PDF file
MHMelissa Heifez
Melissa Heifez
LCLaura Ciria-Suarez
Laura Ciria-Suarez
SMSara Martín‐Parra
Sara Martín‐Parra
IDIlaria Durosini
Ilaria Durosini
DMDario Monzani
Dario Monzani
COCristian Ochoa-Arnedo
Cristian Ochoa-Arnedo
Beyond physical challenges, cancer can cause psychological and cognitive challenges for patients, caregivers, and family members. Digital health interventions show promise in addressing these issues. However, evidence on their applicability in daily cancer care is limited. The objective of this systematic review is to evaluate the internal and external validity of digital health interventions targeting psychological and cognitive impairments in cancer patients, caregivers, and family members, using the RE‐AIM framework. This systematic review was conducted following the PRISMA guidelines, using Pubmed/MEDLINE, Scopus, and PsychINFO databases. Data were extracted using data forms based on the RE‐AIM framework. The methodological quality was assessed using the Quality Assessment Tool for Quantitative Studies (QATQS). A total of 191 studies involving 29.907 patients and caregivers met the inclusion criteria. Included studies were randomized controlled trials and nonrandomized studies of interventions related to digital health, using an online or hybrid format. The reach, implementation, and effectiveness domains were most frequently reported, while adoption and maintenance were the most unreported domains within the RE‐AIM framework. Despite reporting on reach, effectiveness, and implementation, limited data on external validity restricts the impact and scalability of digital health interventions in cancer care. Future research should endeavor to address current challenges and improve the use of digital health interventions in cancer care.